FundedIQ
Biotechnology

Bioheuris

Founded in 2016, Bioheuris develops sustainable weed management systems. The company integrates synthetic biology and gene editing to develop next-generation herbicide resistant crops. Bioheuris expects to bring farmers cost-effective tools that delay weed resistance evolution and reduce environmental impact. With its state-of-the-art technology platforms, HEURIK™ and SWAP™ and strategic alliances with seed and chemical companies, Bioheuris is “Empowering crops® for weed control”.

www.bioheuris.com Rosario, Argentina 11-50 employees
Total raised
$2.0M
Rounds
1
Latest
May 2021

Founded in 2016, Bioheuris develops sustainable weed management systems. The company integrates synthetic biology and gene editing to develop next-generation herbicide resistant crops. Bioheuris expects to bring farmers cost-effective tools that delay weed resistance evolution and reduce environmental impact. With its state-of-the-art technology platforms, HEURIK™ and SWAP™ and strategic alliances with seed and chemical companies, Bioheuris is “Empowering crops® for weed control”.

Bioheuris has raised $2.0M across 1 round. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
May 6, 2021
$2.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Bioheuris is featured in

Similar companies

Kresko RNAtech

Kresko RNAtech is a biotechnology company that offers services for the development and manufacturing of nutraceuticals.

Series Unknown $40k
Bioeutectics

Bioeutectics is committed to improving the sustainability of industrial products and processes by providing superior solvents that are derived from renewable resources, last for a long time, and are environmentally friendly. The company utilizes eutectic technology to replicate the solvent creation process found in plants, using only 100% sustainable resources. This allows them to replace the petrochemical solvents previously used in industrial applications. As a result, they have gained dominance in the market by offering natural alternatives that are beneficial for the environment.

Seed $2.1M
Mycorium Biotech

Mycorium Biotech is a biotechnology startup committed to creating sustainable and eco-friendly materials for the fashion industry, among others. Our primary focus is on mycelium-based leather, a revolutionary alternative to traditional leather. It is a sustainable, cruelty-free, scalable, and innovative material that has the potential to revolutionize the fashion industry, among others. Fashion is in the midst of a sustainability crisis; it is not functional. This industry makes +100Bn items, with +20Bn of CO2 emission per year. We are taking steps to reduce its carbon footprint, by growing the next generation of materials. We are pushing the boundaries of sustainable fashion. We work with a team of experts in biotechnology to ensure that our products are not only sustainable but also of the highest quality. Join us on our journey to create a better and more sustainable future for fashion.

Pre-Seed $250k
VU

VU is a company that focuses specifically on preventing fraud and safeguarding people's identities through cybersecurity measures. They have developed unique methods of identity authentication incorporating biometrics, geolocation, machine learning, ID card recognition, and analysis of user behavior.

Series Unknown $4.2M
ArgenTAG

We are a biotech startup democratizing genomic sequencing applications with proprietary technology. We developed a reliable and robust solution to bring down the cost of applications in long-read sequencers. Our solution consists in a proprietary technology that enables the invention of a myriad of new long-read applications.

$100k
immunitoAI

ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery & therapeutics.

Series A $6.1M
AI Metrics

AI Metrics is an early stage company creating transformational image analysis technology that positions radiologists to be the most efficient, valuable clinicians in the patient care continuum

Venture - Series Unknown $950k
Luminate Medical

Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this.

Venture - Series Unknown $17.0M
Hermes Biosciences

Hermes Biosciences describes a benchtop, hands-off extracellular vesicle isolation system designed to purify exosomes quickly, efficiently.

Seed $6.0M
InvenireX

InvenireX is a biotech company that provides molecular diagnostics services.

Seed $2.6M
Chromologics

Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived from the Technical University of Denmark, this Danish biotech spin-out has established a biotech framework that employs fungi to generate exceptional and eco-friendly colorants.

Venture - Series Unknown $8.1M
Artios Pharma

Artios is an independent DNA Damage Response (DDR) company focused on developing first-in-class treatments for cancer. Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery. Artios is building a pipeline of next-generation DDR programs, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialization arm of Cancer Research UK (CRUK), and with leading DNA repair researchers worldwide. The Company’s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK.

Series D $115M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.